XBiotech Inc.
XBITNasdaqCIK 1626878HealthcareFiscal year ends Dec 31
Reports and events: 134 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0211:13 ET | DEF 14A | Proxy statementPeriod 2026-11-24 | 0001171843-26-006362 |
| 2026-08-1311:26 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001171843-26-005492 |
| 2026-05-1414:43 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001171843-26-003419 |
| 2026-04-2913:02 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001171843-26-002814 |
| 2026-03-1314:33 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001171843-26-001561 |
| 2025-12-0909:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-007836 |
| 2025-11-1211:45 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001171843-25-007233 |
| 2025-10-1512:54 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001171843-25-006441 |
| 2025-10-0311:15 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-006266 |
| 2025-09-0213:10 ET | 8-K | 5.07 Shareholder vote results | 0001171843-25-005673 |
| 2025-08-1314:49 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001171843-25-005368 |
| 2025-07-0717:23 ET | DEF 14A | Proxy statementPeriod 2025-08-29 | 0001193125-25-156276 |
| 2025-06-2417:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-004066 |
| 2025-05-1415:55 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001171843-25-003178 |
| 2025-04-2915:59 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001171843-25-002595 |
| 2025-04-0716:50 ET | 8-K | 3.01 Delisting notice | 0001171843-25-002067 |
| 2025-04-0118:43 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-25-001876 |
| 2025-03-1815:36 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001171843-25-001527 |
| 2024-12-3115:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-24-007128 |
| 2024-11-1315:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001171843-24-006336 |
| 2024-08-1214:38 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001171843-24-004689 |
| 2024-06-2012:57 ET | 8-K | 5.07 Shareholder vote results | 0001171843-24-003541 |
| 2024-05-1011:27 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001171843-24-002746 |
| 2024-05-0116:44 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0001193125-24-127578 |
| 2024-05-0115:32 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001193125-24-127331 |
| 2024-04-2409:57 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001193125-24-108802 |
| 2024-03-1515:31 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001171843-24-001382 |
| 2024-01-0409:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-000056 |
| 2023-11-0914:41 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001171843-23-006944 |
| 2023-08-1111:18 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001171843-23-005261 |
| 2023-06-2315:03 ET | 8-K | 5.07 Shareholder vote results | 0001171843-23-004095 |
| 2023-05-1015:41 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001171843-23-003144 |
| 2023-04-2812:23 ET | DEF 14A | Proxy statementPeriod 2023-06-23 | 0001193125-23-125528 |
| 2023-03-1516:58 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001171843-23-001705 |
| 2023-02-1519:47 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-039510 |
| 2022-11-0915:26 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001171843-22-007285 |
| 2022-08-1017:50 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001171843-22-005546 |
| 2022-06-2911:47 ET | 8-K | 5.07 Shareholder vote results | 0001171843-22-004610 |
| 2022-05-1315:17 ET | DEF 14A | Proxy statementPeriod 2022-06-22 | 0001193125-22-149975 |
| 2022-05-1315:01 ET | 8-K | 4.01 Change of auditor | 0001171843-22-003680 |
| 2022-05-1015:54 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001171843-22-003510 |
| 2022-03-1517:01 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001171843-22-001904 |
| 2022-02-0216:15 ET | 8-K | 1.01 Entry into a material agreement | 0001171843-22-000711 |
| 2021-11-0912:53 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001171843-21-007731 |
| 2021-08-0916:10 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001171843-21-005700 |
| 2021-07-0617:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-21-004741 |
| 2021-05-1017:15 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001171843-21-003353 |
| 2021-04-2918:12 ET | DEF 14A | Proxy statementPeriod 2021-06-22 | 0001171843-21-002901 |
| 2021-03-1616:28 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001171843-21-001828 |
| 2020-11-0917:28 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001171843-20-007826 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 09:40 ET. Listed shows no prices and gives no investment advice.